As ligation of PD-L1 to PD-1 interferes with TCR signaling and attenuates the effector function of anti-tumoral T cells 18,37, these results provide a rationale for early PD-L1 blockade in combination with cancer vaccination. The gene discussed is CD274; the disease is cancer.